Osimertinib Improves Overall Survival in Patients with Leptomeningeal Metastases Associated with EGFR-Mutated Non-Small-Cell Lung Cancer Regardless of Cerebrospinal Fluid T790M Mutational Status
Type
Retraction
Notice date
7/12/2023 0:00
Journal
Evidence-Based Complementary and Alternative Medicine